Purchase Order 36C24619P0537
- Not listed
- The Department of Veterans Affairs Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $157,436.96 contract, which did not have a set-aside designation, was for immunohistochemistry products and services. Roche Diagnostics has been awarded numerous federal contracts to provide medical equipment, supplies, and services to agencies such...
- The Department of Veterans Affairs Veterans Health Administration awarded a $458,322.56 firm-fixed-price delivery order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for molecular pathology products and services. The contract does not have a set-aside designation. Roche Diagnostics is a foreign-owned, for-profit manufacturer that has provided medical equipment, reagents, and laboratory services to various federal agencies through prime contracts and subcontracts,...
- The Department of Veterans Affairs Veterans Health Administration awarded a Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics, reagents, and laboratory equipment. The $342,604.03 Firm Fixed Price contract is for the supply of ROCHE EQUIPMENT SUPPLIES AND REAGENT and has a completion date of September 30, 2023. The contract is not set aside for any socioeconomic category. Roche Diagnostics holds several Indefinite Delivery Contracts and...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $23,741.00 Firm Fixed Price Delivery Order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory equipment. This contract is for the provision of coagulation testing supplies to support VA healthcare facilities. The contract has no set-aside designation and a completion date of January 31, 2024. Roche Diagnostics holds several Indefinite...
- The Department of Veterans Affairs Veterans Health Administration awarded a $863,381.55 firm-fixed price delivery order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, for immunohistochemistry products and services. This order was not set aside for any particular business type. Roche Diagnostics has been awarded multiple federal contracts to provide critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services to the VA,...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a purchase order contract to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, a foreign-owned for-profit manufacturer. The $161,459.20 firm-fixed-price contract is for the annual requirement of VENTANA reagents, with a completion date of January 12, 2021. Roche Diagnostics is a provider of in vitro diagnostics, reagents, laboratory instruments, and associated products and services to various...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and related laboratory equipment and supplies. The $176,874.00 contract provides reagents for use at VA facilities without any set-aside designation. Roche Diagnostics has held numerous federal contracts and subcontracts to supply critical care analyzers, test kits,...
- The Department of Veterans Affairs Veterans Health Administration awarded a $426,490.53 firm-fixed-price delivery order to Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. This order was placed against Roche's existing General Services Administration (GSA) Schedule contract for critical care analyzers and related laboratory equipment and supplies. The award provides chemistry analysis capabilities, including...
- The Department of Veterans Affairs Veterans Health Administration awarded a $1,289,687.51 firm fixed price delivery order contract to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer, to provide critical care analyzers, reagents, test kits, and associated laboratory equipment, supplies, and services. This award was made under Roche's existing General Services Administration (GSA) Schedule contract for laboratory instruments, equipment, and supplies. Roche has received...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $112,018.90 firm-fixed-price delivery order was placed against Roche's existing General Services Administration (GSA) Schedule contract for Critical Analyzers and Laboratory Equipment (FSS-66-III). This order provides the VA with clinical chemistry...
The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed-price purchase order to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer and distributor of in vitro diagnostics, to provide maintenance services for a Roche HE 600 analyzer. The $172,500.57 contract was awarded on February 27, 2019, with a completion date of February 21, 2023. Roche Diagnostics has previously received awards from the VA, Department of Defense, Department of Health and Human Services, and other federal agencies to supply clinical chemistry analyzers, reagents, and associated laboratory equipment, supplies, and services. Roche holds multiple General Services Administration (GSA) schedule contracts and Indefinite Delivery Contracts/Blanket Purchase Agreements that allow federal customers to acquire Roche's products and services on an as-needed basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00003 | Exercise an Option | $30.4k | 2/22/22 | |
| P00002 | Funding Only Action | $29.0k | 2/19/21 | |
| P00001 | Exercise an Option | $27.6k | 2/26/20 | |
| Not listed | Not listed | $28.9k | 2/27/19 |